# Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery

> **NCT00842452** · PHASE1 · COMPLETED · sponsor: **Steven Waggoner, MD** · enrollment: 26 (actual)

## Conditions studied

- Cervical Cancer
- Endometrial Cancer
- Fallopian Tube Cancer
- Ovarian Cancer
- Sarcoma
- Vaginal Cancer
- Vulvar Cancer

## Interventions

- **DRUG:** topotecan hydrochloride
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00842452
- **Lead sponsor:** Steven Waggoner, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2013-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842452, "Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00842452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*